KY Biotechnology & Medical Research

Silexion Therapeutics Corp (SLXN)

Track

Silexion Therapeutics Corp recorded its latest insider activity on March 26, 2026. CSO and CDO Shirvan Mitchell executed a sale of 22,818 shares, totaling approximately 31,032 dollars. No further transactions have been reported by company leadership within the last three months, indicating a period of inactivity regarding equity movements by corporate officers.
Ticker: SLXN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Silexion Therapeutics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Shirvan Mitchell CSO and CDO Officer
Transaction date
Sale
Price
101.67
Quantity 99,778 +15.9%
Value US$3,287,918
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-26 S Sale
3.4
Shirvan Mitchell

CSO and CDO

Officer
99,778 +15.9%
101.67
US$3,287,918 		99,778 +15.9% 101.67 US$3,287,918
Explore more

More insider trading research around Silexion Therapeutics Corp

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity